Acasti Pharma Inc RSI
What is the RSI of Acasti Pharma Inc?
The RSI of Acasti Pharma Inc is 36.12
What is the definition of RSI?
The relative strength index (RSI 14) is a momentum indicator that compares the magnitude of gains and losses over a specified time period to measure speed and change of price movements of a security.
14-day period
It is used to identify overbought or oversold conditions in the trading of an asset. It oscillates between 0 and 100 and a stock is considered overbought when the RSI is above 70 and oversold when below 30. The relative strength index (RSI) is typically used on a 14-day timeframe and is calculated according to the formula 100 - [ 100 / (1 + RS)] where RS is the ratio of average gain to average loss. In the calculation of average gain and loss for a certain period, taking the prior value plus the current value is a smoothing technique similar to that used in calculating an exponential moving average. This also means that RSI values become more accurate as the calculation period extends.
Sudden large price movements can create false buy or sell signals in the RSI. The RSI is often used in conjunction with trend lines, as trend line support or resistance often coincides with support or resistance levels in the RSI reading. Watching for divergence between price and the RSI indicator is another means of refining its application. Divergence occurs when a security makes a new high or low in price but the RSI does not make a corresponding new high or low value. Bearish divergence, when price makes a new high but the RSI does not is taken as a sell signal. Bullish divergence that is interpreted as a buy signal occurs when price makes a new low, but the RSI value does not.
RSI of companies in the Health Care sector on NASDAQ compared to Acasti Pharma Inc
What does Acasti Pharma Inc do?
acasti pharma, inc., a subsiduary of neptune technologies & bioressources, is a quebec-based biopharmaceutical dedicated in advancing a proprietary portfolio based on marine phospholipids. our products can be used in prescription, medical food and over-the-counter applications, either as a stand-alone, or, as a fixed-dose combination to exisitng productrs, for the prevention and treatment of cardiometabolic disorders.
Companies with rsi similar to Acasti Pharma Inc
- Josemaria Resources has RSI of 36.10
- FireEye Inc has RSI of 36.10
- Puma VCT 11 has RSI of 36.11
- Olin has RSI of 36.11
- Cue Biopharma Inc has RSI of 36.11
- Oasis Petroleum has RSI of 36.11
- Acasti Pharma Inc has RSI of 36.12
- Gorman-Rupp Co has RSI of 36.13
- Imunon Inc has RSI of 36.13
- Union Bank of India has RSI of 36.13
- Vianet plc has RSI of 36.13
- Abercrombie & Fitch Co has RSI of 36.13
- Base Resources has RSI of 36.14